Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 4Cl.2K.Pt |
| Molecular Weight | 415.093 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Cl-].[Cl-].[Cl-].[K+].[K+].[Pt++]
InChI
InChIKey=RVRDLMCWUILSAH-UHFFFAOYSA-J
InChI=1S/4ClH.2K.Pt/h4*1H;;;/q;;;;2*+1;+2/p-4
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | K |
| Molecular Weight | 39.0983 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Pt |
| Molecular Weight | 195.084 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Potassium tetrachloroplatinate is used in the preparation of platinum (Pt) nanoparticles. Ligands like ammonia or triphenyl phosphine can able to replace the chloride ligands to afford various derivatives. The replacement by ammonia results in the preparation of cisplatin, which is used in the cancer treatment. Further, it is used as catalyst in the hydroarylation reaction. Cisplatin and potassium tetrachloroplatinate are shown to bind to DNA that encapsulates SWNTs in aqueous solution. The bound platinum salt can then be reduced to decorate the DNA-encapsulated SWNTs with platinum nanoparticles. The unique combination of catalytic activity of nanoscale platinum, biological functionality of DNA, and optoelectronic properties of SWNTs suggests a myriad of applications including fuel cells, catalysts, biosensors, and electrochemical devices.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1909490 |
|||
Target ID: CHEMBL3070 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19702435 |
|||
Target ID: CHEMBL3730 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3569272 |
|||
Target ID: CHEMBL5917 Sources: https://www.ncbi.nlm.nih.gov/pubmed/166679 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Prediction of the contact sensitizing potential of chemicals using analysis of gene expression changes in human THP-1 monocytes. | 2010-11-10 |
|
| Interleukin-1beta and surface marker expression changes induced by tetrachloroplatinate in human monocyte-derived dendritic cells. | 2010-03 |
|
| Detection of immunotoxicity using T-cell based cytokine reporter cell lines ("Cell Chip"). | 2005-01-15 |
|
| Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. | 2002-12 |
|
| Specific inhibition of rRNA transcription and dynamic relocation of fibrillarin induced by mercury. | 2000-08-25 |
|
| Inhibition of HIV-1 proteinase by metal ions. | 1992-06 |
Sample Use Guides
In Vivo Use Guide
Sources: http://datasheets.scbt.com/sc-264138.pdf
Oral (Human) LD: 400 mg/kg
Oral (Human) TDLo: 8.571 mg/kg
Dermal (Human) TDLo: 40 mg/kg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19702435
Potassium tetrachloroplatinate (150 uM) induced up-regulation of IL-1beta mRNA, CD54, CD86, but not HLA-DR expression on in vitro cultured human monocyte-derived dendritic cells (MoDCs).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:57:31 GMT 2025
by
admin
on
Mon Mar 31 19:57:31 GMT 2025
|
| Record UNII |
B74O00UCWC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
175496
Created by
admin on Mon Mar 31 19:57:31 GMT 2025 , Edited by admin on Mon Mar 31 19:57:31 GMT 2025
|
PRIMARY | |||
|
233-050-9
Created by
admin on Mon Mar 31 19:57:31 GMT 2025 , Edited by admin on Mon Mar 31 19:57:31 GMT 2025
|
PRIMARY | |||
|
61440
Created by
admin on Mon Mar 31 19:57:31 GMT 2025 , Edited by admin on Mon Mar 31 19:57:31 GMT 2025
|
PRIMARY | |||
|
m9071
Created by
admin on Mon Mar 31 19:57:31 GMT 2025 , Edited by admin on Mon Mar 31 19:57:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID10904020
Created by
admin on Mon Mar 31 19:57:31 GMT 2025 , Edited by admin on Mon Mar 31 19:57:31 GMT 2025
|
PRIMARY | |||
|
B74O00UCWC
Created by
admin on Mon Mar 31 19:57:31 GMT 2025 , Edited by admin on Mon Mar 31 19:57:31 GMT 2025
|
PRIMARY | |||
|
POTASSIUM TETRACHLOROPLATINATE
Created by
admin on Mon Mar 31 19:57:31 GMT 2025 , Edited by admin on Mon Mar 31 19:57:31 GMT 2025
|
PRIMARY | |||
|
10025-99-7
Created by
admin on Mon Mar 31 19:57:31 GMT 2025 , Edited by admin on Mon Mar 31 19:57:31 GMT 2025
|
PRIMARY |